Request for COVID Vaccine Prioritization

Life Science Washington submitted the letter below to theWashington Department of Health requesting that two groups of high-risk essential life science employees be prioritized for early access to COVID-19 vaccines.  Our letter is consistent with BIO and AdvaMed requests for prioritization in the CDC’s Advisory Council on Immunization Practices (ACIP) framework.

Access the letter here.

Posted on Updated:
Share:
Related Resources
  • Industry Reports
  • 2023

2023 Washington State Investor Report
  • Industry Reports
  • 2022

2022 Economic Impact Report
  • Industry Reports
  • 2024

Washington State Life Science Investment Report – February 2024
  • Policy Agenda
  • 2024

2024 Legislative Outcomes

60 days of policymaking and passing updates to state budgets concluded on March 7 when Washington’s annual state legislative session adjourned. Similar to last year, Life Science Washington (LSW) had a modest legislative agenda of budget priorities and policy bills to monitor, support, or seek to improve. In the end, legislators largely declined to make […]